Fibrogenic cytokines and extent of fibrosis in muscle of dogs with X-linked golden retriever muscular dystrophy.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Neuromuscular Disorders

• Publication date

  2002-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0960-8966(02)00071-8PMID 12398833
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Development of muscle pathology in canine X-linked muscular dystrophy. II. Quantitative characterization of histopathological progression during postnatal skeletal muscle development

  2001cited by this paper
• Impact of prednisone on TGF‐β1 and collagen in diaphragm muscle from mdx mice

  2001cited by this paper
• Three mouse models of muscular dystrophy: the natural history of strength and fatigue in dystrophin-, dystrophin/utrophin-, and laminin alpha2-deficient mice.

  2001cited by this paper
• Changes of skeletal muscle in young dystrophin-deficient cats: a morphological and morphometric study

  2001cited by this paper
• Role of transforming growth factor beta in human disease.

  2000cited by this paper
• A preliminary study of long-term treatment with interferon gamma-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis.

  1999cited by this paper
• Development of muscle pathology in canine X-linked muscular dystrophy. I. Delayed postnatal maturation of affected and normal muscle as revealed by myosin isoform analysis and utrophin expression

  1999cited by this paper
• Transforming growth factor-beta dynamically regulates vascular smooth muscle differentiation in vivo.

  1998cited by this paper
• The muscular dystrophies

  1998cited by this paper
• Transforming growth factor-beta (TGF-beta).

  1998cited by this paper
• Connective tissue growth factor: a mediator of TGF-β action on fibroblasts

  1997cited by this paper
• Hypertrophic scars, keloids, and contractures. The cellular and molecular basis for therapy.

  1997cited by this paper
• Stretch-induced VEGF expression in the heart.

  1997cited by this paper
• Connective tissue growth factor: a mediator of TGF-beta action on fibroblasts.

  1997cited by this paper
• A novel transforming growth factor beta response element controls the expression of the connective tissue growth factor gene.

  1996cited by this paper
• Fluid shear stress induces endothelial transforming growth factor beta-1 transcription and production. Modulation by potassium channel blockade.

  1995cited by this paper
• Expression of transforming growth factor-beta 1 in dystrophic patient muscles correlates with fibrosis. Pathogenetic role of a fibrogenic cytokine.

  1995cited by this paper
• Rapid construction of deleted DNA fragments for use as internal standards in competitive PCR.

  1994cited by this paper
• Transforming Growth Factor β as a Predictor of Liver and Lung Fibrosis after Autologous Bone Marrow Transplantation for Advanced Breast Cancer

  1993cited by this paper
• Transforming growth factor beta as a predictor of liver and lung fibrosis after autologous bone marrow transplantation for advanced breast cancer.

  1993cited by this paper
• Transforming growth factor-beta protein and mRNA in glomeruli in normal and diseased human kidneys.

  1993cited by this paper
• The muscular dystrophies.

  1992cited by this paper
• Transforming growth factors beta 1 and alpha in chronic liver disease. Effects of interferon alfa therapy.

  1991cited by this paper
• Animal models of muscular dystrophy – what can they teach us?

  1991cited by this paper
• Canine X-linked muscular dystrophy: morphologic lesions.

  1990cited by this paper
• The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion.

  1989cited by this paper
• Canine X-linked muscular dystrophy. An animal model of Duchenne muscular dystrophy: clinical studies.

  1988cited by this paper
• The homologue of the Duchenne locus is defective in X-linked muscular dystrophy of dogs

  1988cited by this paper
• Muscular dystrophy in a litter of golden retriever dogs

  1988cited by this paper
• Dystrophin: the protein product of the Duchenne muscular dystrophy locus.

  1987cited by this paper
• Complement activation in muscle fiber necrosis: Demonstration of the membrane attack complex of complement in necrotic fibers

  1982cited by this paper
• Collagen localization in normal and fibrotic human skeletal muscle.

  1981cited by this paper

• Pamrevlumab, a Fully Human Monoclonal Antibody Targeting Connective Tissue Growth Factor, for Non-Ambulatory Patients with Duchenne Muscular Dystrophy

  2023influential citation
• Identification and characterization of long non-coding RNAs in muscle sclerosis of grass carp, Ctenopharyngodon idellus fed with faba bean meal

  2020cites this paper
• Immunobiology of Inherited Muscular Dystrophies.

  2018cites this paper
• Connective tissue growth factor (CTGF) from basics to clinics.

  2018cites this paper
• Expression of CTGF/CCN2 in response to LPA is stimulated by fibrotic extracellular matrix via the integrin/FAK axis.

  2018cites this paper
• Elevated Expression of Moesin in Muscular Dystrophies.

  2017cites this paper
• Pharmacological therapeutics targeting the secondary defects and downstream pathology of Duchenne muscular dystrophy

  2016cites this paper
• Skeletal Muscle Fibrosis in the mdx/utrn+/- Mouse Validates Its Suitability as a Murine Model of Duchenne Muscular Dystrophy

  2015cites this paper
• Immune-mediated pathology in Duchenne muscular dystrophy

  2015cites this paper
• Dystrophin-deficient large animal models: translational research and exon skipping.

  2015cites this paper
• Role of CTGF and TNF on fibrosis in muscular dystrophy

  2014cites this paper
• Motor Physical Therapy Affects Muscle Collagen Type I and Decreases Gait Speed in Dystrophin-Deficient Dogs

  2014cites this paper
• Gene Expression Profiling of Grass Carp (Ctenopharyngodon idellus) and Crisp Grass Carp

  2014cites this paper
• Adipose Tissue-Derived Stem Cell Secreted IGF-1 Protects Myoblasts from the Negative Effect of Myostatin

  2014cites this paper
• Role of Wnt signaling in tissue fibrosis, lessons from skeletal muscle and kidney.

  2014cites this paper
• Wnt Signaling in Skeletal Muscle Dynamics: Myogenesis, Neuromuscular Synapse and Fibrosis

  2014cites this paper
• Pharmacologic management of Duchenne muscular dystrophy: target identification and preclinical trials.

  2014cites this paper
• Role of proteoglycans in the regulation of the skeletal muscle fibrotic response

  2013cites this paper
• Bortezomib (PS-341) Treatment Decreases Inflammation and Partially Rescues the Expression of the Dystrophin-Glycoprotein Complex in GRMD Dogs

  2013cites this paper
• Cytokines and Chemokines as Regulators of Skeletal Muscle Inflammation: Presenting the Case of Duchenne Muscular Dystrophy

  2013cites this paper
• Reducing CTGF/CCN2 slows down mdx muscle dystrophy and improves cell therapy.

  2013cites this paper
• Cytokines and Chemokines as Regulators of Skeletal Muscle Inflammation: Presenting the Case of Duchenne Muscular Dystrophy

  2013cites this paper
• Novel Approach to Meta-Analysis of Microarray Datasets Reveals Muscle Remodeling-related Drug Targets and Biomarkers in Duchenne Muscular Dystrophy

  2012cites this paper
• Donor Satellite Cell Engraftment is Significantly Augmented When the Host Niche is Preserved and Endogenous Satellite Cells are Incapacitated

  2012cites this paper
• Emerging drugs for Duchenne muscular dystrophy

  2012cites this paper
• Connective tissue growth factor induction by lysophosphatidic acid requires transactivation of transforming growth factor type β receptors and the JNK pathway.

  2011cites this paper
• Halofuginone and muscular dystrophy.

  2011cites this paper
• 19 – Treatment and Management of Muscular Dystrophies

  2011cites this paper
• Mechanisms of muscle injury, repair, and regeneration.

  2011cites this paper
• Role of TGF-β signaling in inherited and acquired myopathies

  2011cites this paper
• Chronic Losartan Administration Reduces Mortality and Preserves Cardiac but Not Skeletal Muscle Function in Dystrophic Mice

  2011cites this paper
• Arginine Metabolism by Macrophages Promotes Cardiac and Muscle Fibrosis in mdx Muscular Dystrophy

  2010cites this paper
• In: Braund's Clinical Neurology in Small Animals: Localization, Diagnosis and Treatment, C.H. Vite (Ed.)

  2010cites this paper
• Fibrotic pathways in the dystrophin deficient heart

  2009influential citation
• Golden Retriever Muscular Dystrophy (GRMD) como modelo morfofuncional da reparação tecidual na Distrofia Muscular de Duchenne

  2009cites this paper
• Collagen types analysis and differentiation by FTIR spectroscopy

  2009cites this paper
• Effect of physical therapy on joint range of motion and muscle collagen deposition in the golden retriever muscular dystrophy (GRMD) model

  2009cites this paper
• Influência do bloqueador de receptor de angiotensina (Losartana potássica) na função renal e pressão arterial em cães GRMD

  2009cites this paper
• Novel regulatory mechanisms for the proteoglycans decorin and biglycan during muscle formation and muscular dystrophy.

  2008cites this paper
• Major basic protein-1 promotes fibrosis of dystrophic muscle and attenuates the cellular immune response in muscular dystrophy.

  2008cites this paper
• Skeletal muscle cells express the profibrotic cytokine connective tissue growth factor (CTGF/CCN2), which induces their dedifferentiation

  2008cites this paper
• Connective tissue growth factor is overexpressed in muscles of human muscular dystrophy.

  2008cites this paper
• A comparison of factors associated with collagen metabolism in different skeletal muscles from dystrophic (mdx) mice: Impact of pirfenidone

  2007cites this paper
• Constitutively activated dystrophic muscle fibroblasts show a paradoxical response to TGF-β and CTGF/CCN2

  2007cites this paper
• First evaluation of the potential effectiveness in muscular dystrophy of a novel chimeric compound, BN 82270, acting as calpain-inhibitor and anti-oxidant.

  2006cites this paper
• AvaliaÁªo comparativa das alteraÁies morfolÛgicas nas cØlulas musculares estriadas em cªes Golden Retriever acometidos e nªo acometidos por distrofia muscular do tipo Duchenne

  2006cites this paper
• Temporal and spatial mRNA expression patterns of TGF-beta1, 2, 3 and TbetaRI, II, III in skeletal muscles of mdx mice.

  2006cites this paper
• Long‐term administration of pirfenidone improves cardiac function in mdx mice

  2006cites this paper
• Transforming growth factor-beta enhances connective tissue growth factor expression in L6 rat skeletal myotubes.

  2005cites this paper
• Modifying function and fibrosis of cardiac and skeletal muscle from mdx mice

  2005cites this paper
• Microvessel density in muscles of dogs with golden retriever muscular dystrophy.

  2005cites this paper
• Cardiomyopathy in dystrophin-deficient hearts is prevented by expression of a neuronal nitric oxide synthase transgene in the myocardium.

  2005cites this paper
• Molecular Pathogenesis of Genetic and Inherited Diseases A Multidisciplinary Evaluation of the Effectiveness of Cyclosporine A in Dystrophic Mdx Mice

  2005cites this paper
• In : Braund ' s Clinical Neurology in Small Animals : Localization , Diagnosis and Treatment

  2004cites this paper
• Familial Dysphagia Central Core Myopathy Devon Rex Cat Hereditary Myopathy Exertional Myopathy Fibrotic Myopathy Glycogenosis Hepatozoon Myositis Hyperadrenocortical (Cushing's) Myopathy Hyperkalemic Myopathy Hypernatremic Myopathy Hypokalemic Myopathy Hypothyroid Myopathy Hypotrophic Myopathy Immob

  2003cites this paper
• Treatment ofmuscular dystrophies : present and future

  2003cites this paper
• Duchenne's muscular dystrophy: animal models used to investigate pathogenesis and develop therapeutic strategies

  2003cites this paper